UK oncology researchers have come together to write the first ever national thought leadership strategy report into cancer vaccine advances and the opportunities these present for those affected by cancer. The strategy report has been published in Cambridge University Press journal Cambridge Prisms: Precision Medicine. Cancer vaccines hold the potential to revolutionise cancer treatment. These … Read more
Researchers at The University of Hong Kong (HKU) have made an exciting discovery about how human cells protect DNA during cell division, offering new insights into combating diseases such as cancer. Led by Professor Gary Ying Wai CHAN from the School of Biological Sciences, Faculty of Science, and Professor Ken Hoi Tang MA from the … Read more
Humans are continuously exposed to various environmental allergens (antigens), such as pollen, food, and dust mites. In certain individuals, their immune system recognizes common environmental antigens as foreign substances, resulting in the production of allergy-related antibodies known as immunoglobulin E (IgE). This condition, wherein IgE antibodies specific to common environmental allergens are produced in the … Read more
Infertility is a problem that affects between 8% and 12% of couples of reproductive age worldwide – for some of them, the problem interrupts a life project, which is the desire to have children and build a family. Advances in technology and medicine have made assisted reproductive treatments possible, but they can be physically and … Read more
Uncovering the Molecular Timer of Pregnancy News Medical is excited to bring you the latest breakthrough in pregnancy research from UC San Francisco (UCSF) scientists. They have discovered… The post Discovering a Molecular Timer for Pregnancy in Mice appeared first on NewsyList. Source link
Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Duke-NUS Medical School have provided compelling evidence that short-course antibiotic treatments can be a game-changer in tackling ventilator-associated pneumonia (VAP), a … Read more
Andrew C. Stokes, PhD Credit: Boston University Patient factors, including sociodemographic, healthcare, and clinical elements, were linked to the initiation of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), in a population with obesity without type 2 diabetes (T2D).1 Among more than 97,000 commercially insured adults in a recent cohort study, approximately 2.0% began semaglutide … Read more
Sizheng Steven Zhao, MBChB, PhD Credit: LinkedIn JAK inhibitor (JAKi) therapy was not associated with an increased risk of cardiovascular disease, venous thromboembolism (VTE), or some cancers in people with psoriatic arthritis (PsA) and spondyloarthritis (SpA) compared to TNF inhibitors (TNFi) or IL-17 inhibitors (IL-17i).1 “Compared to TNFi, tofacitinib was shown to increase risk of … Read more
With viral disease emergence expected to accelerate, preparing for possible future pandemics is paramount. Beyond saving lives during outbreaks, robust pandemic preparedness safeguards economies, sustains societal functioning, and reinforces the resilience of global systems. The new EU project COMBINE (“Comparative Signature of Marburg Virus Cell Activation as a Blueprint for the Identification of Antiviral Targets … Read more
New research is providing clinicians with an overview of the association between cardiovascular health and the risk of developing metabolic dysfunctional-associated steatotic liver disease (MASLD).1 Leveraging National Health and Nutrition Examination Survey (NHANES) 2017-March 2020 data and using the American Heart Association (AHA)’s Life’s Essential 8 (LE8) score as a benchmark of cardiovascular health, investigators … Read more